No it doesn't need COVID, it can continue operating with no revenue. Missing out on a major medical problem, overstating the value and using poor science isn't going to rattle the faith of institutional and retail investors.
HGEN sold itself hard as a COVID company, now it has to make good.
Market Data 
Markets 
AI
